[go: up one dir, main page]

Sorkin et al., 1993 - Google Patents

Pool of ligand‐bound platelet‐derived growth factor β‐receptors remain activated and tyrosine phosphorylated after internalization

Sorkin et al., 1993

Document ID
10785265438838657573
Author
Sorkin A
Eriksson A
Heldin C
Westermark B
Claesson‐Welsh L
Publication year
Publication venue
Journal of cellular physiology

External Links

Snippet

We have examined the state of tyrosine phosphorylation of ligand‐bound, internalized platelet‐derived growth factor (PDGF) β‐receptors. Analysis by immunofluorescence staining of cells stimulated with PDGF‐BB at 370C indicated colocalization of …
Continue reading at onlinelibrary.wiley.com (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/502—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics for testing non-proliferative effects
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/71—Receptors; Cell surface antigens; Cell surface determinants for growth factors; for growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/475—Growth factors; Growth regulators
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/177—Receptors; Cell surface antigens; Cell surface determinants

Similar Documents

Publication Publication Date Title
Sorkin et al. Pool of ligand‐bound platelet‐derived growth factor β‐receptors remain activated and tyrosine phosphorylated after internalization
Ansel et al. Human keratinocytes are a major source of cutaneous platelet-derived growth factor.
Khoshnoodi et al. Nephrin promotes cell-cell adhesion through homophilic interactions
Chen et al. Homomeric interactions between type II transforming growth factor-beta receptors.
Massagué et al. TGF‐β receptors
Kuroda et al. Biochemical characterization and expression analysis of neural thrombospondin-1-like proteins NELL1 and NELL2
Damen et al. Phosphatidylinositol 3-kinase associates, via its Src homology 2 domains, with the activated erythropoietin receptor
Zabrecky et al. The extracellular domain of p185/neu is released from the surface of human breast carcinoma cells, SK-BR-3
Shi et al. Control of fibroblast growth factor receptor kinase signal transduction by heterodimerization of combinatorial splice variants
Cook et al. Solubilization, purification, and reconstitution of the sodium-calcium exchanger from bovine retinal rod outer segments.
Kazlauskas et al. Different effects of homo‐and heterodimers of platelet‐derived growth factor A and B chains on human and mouse fibroblasts.
Heldin Structural and functional studies on platelet-derived growth factor
Letamendı́a et al. Role of endoglin in cellular responses to transforming growth factor-β: a comparative study with betaglycan
Mikelis et al. Integrin αvβ3 is a pleiotrophin receptor required for pleiotrophin‐induced endothelial cell migration through receptor protein tyrosine phosphatase β/ζ
Banerjee et al. GW domains of the Listeria monocytogenes invasion protein InlB are required for potentiation of Met activation
Pi et al. Connective tissue growth factor with a novel fibronectin binding site promotes cell adhesion and migration during rat oval cell activation
McKeehan et al. Heparan sulfate fibroblast growth factor receptor complex: Structure‐function relationships
Neidhardt et al. Tenascin-N: characterization of a novel member of the tenascin family that mediates neurite repulsion from hippocampal explants
Seifert et al. PDGF-AB requires PDGF receptor alpha-subunits for high-affinity, but not for low-affinity, binding and signal transduction.
Raikwar et al. Protein kinase C regulates FLT1 abundance and stimulates its cleavage in vascular endothelial cells with the release of a soluble PlGF/VEGF antagonist
AU718795B2 (en) Netrin receptors
Nånberg et al. Demonstration of functionally different interactions between phospholipase C-γ and the two types of platelet-derived growth factor receptors
Li et al. Platelet-derived growth factor (PDGF)-induced disulfide-linked dimerization of PDGF receptor in living cells
Kuns-Hashimoto et al. Selective binding of RGMc/hemojuvelin, a key protein in systemic iron metabolism, to BMP-2 and neogenin
Lecrone et al. Calcium signals in prostate cancer cells: specific activation by bone-matrix proteins